ethosuximide has been researched along with Hyperplasia in 2 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Masruha, MR | 1 |
Marques, CM | 1 |
Vilanova, LC | 1 |
de Seixas Alves, MT | 1 |
Peres, MF | 1 |
Rodrigues, MG | 1 |
Ojinnaka, NC | 1 |
Iloeje, SO | 1 |
2 other studies available for ethosuximide and Hyperplasia
Article | Year |
---|---|
Drug induced pseudolymphoma secondary to ethosuximide.
Topics: Anticonvulsants; Biopsy; Child; Ethosuximide; Humans; Hyperplasia; Lymph Nodes; Male; Pseudolymphoma | 2005 |
Ethosuximide induced lymphadenopathy--a case report.
Topics: Anticonvulsants; Child; Epilepsy, Absence; Ethosuximide; Female; Humans; Hyperplasia; Lymphatic Dise | 2001 |